RaDIANT Health Systems Intervention
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Indiana University
- Study ID
- NCT07033117
- Status
- Recruiting
Conditions
- End Stage Renal Disease (ESRD)
- Kidney Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Performance Feedback Reports on Referral and Evaluation Closures — OTHERPerformance feedback reports will reflect each transplant center's performance related to kidney transplant evaluation initiation and referral closure. These reports aim to help centers understand common reasons why patients do not initiate the evaluation process or failed to proceed beyond the evaluation process, and to identify patterns in referral and evaluation closure practices. Reports will be individualized and distributed quarterly to the transplant center champion by the intervention lead.
- Dialysis Facility Awareness Campaign — OTHERAs part of the intervention, dialysis centers will participate in an Awareness Campaign designed to educate staff about transplant center quality improvement efforts and how they may be contacted as part of the project. This campaign may include brief webinars or informative documents distributed via platforms such as IPRO Learn.
- Patient Contact via Preferred Method — OTHERTransplant centers will contact patients using their preferred method of communication.
- Phone Call to Dialysis Facility During the Patient's Dialysis Session — OTHERFacilities will enhance their patient communication procedures by making a phone call to the dialysis facility during the patient's dialysis session if the patient has not responded to initial outreach attempts. This additional step increases the likelihood of reaching the patient during a time when they are accessible and can engage in scheduling or follow-up.
- Phone Call to Provider — OTHERTransplant centers will enhance their outreach procedures by making a phone call to the referring provider (e.g., nephrologist, medical assistant) or another provider involved in the patient's care (e.g., primary care provider) in the event of self-referral if the patient has not responded to initial outreach attempts or "no-shows" an initial evaluation appointment. This additional step ensures that the referring provider is informed of the patient's progress and can assist in re-engagement or decision-making prior to referral closure.
- Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show — OTHERTransplant center staff will utilize transplant referral communication platforms and/or email to communicate updates to dialysis staff regarding patient status (e.g., unable to contact the patient or no-show) before referral closure.
- Audit and Tracking of Patient Contact Attempts Prior to Referral Closure — OTHERTransplant center staff will continue internally tracking the frequency that a patient is contacted before closure and the date of closure, in alignment with center standard practice. This intervention introduces an audit process to be conducted before closure to ensure that all contact attempts (including one or more attempts to contact the patient directly, one or more phone calls to the alternate preferred contact, or one or more attempted contacts to the dialysis unit to connect with the patient), in alignment with center communication procedures, are appropriately executed.
Study Details
The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.
Key Dates
- Start date
- Oct 27, 2025
- Status verified
- May 2026
- Primary completion
- Mar 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 14,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Multi-Component InterventionFive participating transplant centers will multicomponent intervention in their management of patients referred to their transplant center for a kidney transplantation. The intervention will consist of: (1) required performance feedback reports on closed referrals; and a set of optional components that may be implemented variably by centers, including; (2) contacting patients via their preferred method; (3) phone calls to the dialysis facility during the patient's dialysis session; (4) phone calls to the referring or other provider; (5) use of a multi-module, secure, web-enabled software application called Transplant Referral EXchange (T-REX) or secure email to communicate patient status and no-show information; and (6) communication tracking and audit. Dialysis facilities in GA, NC, SC, and IN will receive resources to support an awareness campaign to support implementation of intervention activities within transplant centers.
Primary Outcome Measure
Change in transplant evaluation start within 6 months of transplant referral [ Time Frame: Baseline, Post Intervention (Up to one year) ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory Transplant Center | Atlanta | Georgia | 30322 | |
| Piedmont Transplant Institute | Atlanta | Georgia | 30309 | |
| IU Health Transplant - Indianapolis | Indianapolis | Indiana | 46202 | |
| Duke Transplant Center | Durham | North Carolina | 27710 | |
| MUSC Mid-Carolinas Transplant Center | Lancaster | South Carolina | 29720 |
Find similar trials in Atlanta, GA
Related Studies
- A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal DiseaseRecruiting · W.L.Gore & Associates · Phoenix, Arizona
- To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisPHASE3 · Recruiting · Humacyte, Inc. · Scottsdale, Arizona
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyPHASE3 · Recruiting · Takeda · Birmingham, Alabama
- A Multicenter, Prospective Blood Collection Study in a Kidney Transplant PopulationRecruiting · Devyser Inc. · San Diego, California